Dublin, March 06, 2025 (Globe Newswire) – The “Report on the landscape of patents of artificial intelligence in the medical diagnosis and forecast 2024-2032” The report was added to Researchandmarkets.com offer.
The global market for artificial intelligence in medical diagnosis has demonstrated considerable growth, with an estimated value of USD 1.22 billion in 2023. Experts foresee an annual growth rate (TCAC) of 36.1% over the period of 2024-2032. AI algorithms, the integration of advanced imaging technologies and sophisticated data analysis.
World patent trends and key innovations
The current patented landscape of artificial intelligence in medical diagnosis shows a wide range of patented innovations, emphasizing the improvement of the precision and the efficiency of the diagnosis. In particular, more than 15,000 patents have been filed by stressing the importance of AI in the progression of health care technology, with particular emphasis on personalized treatment solutions and improving the results for patients.
Sector leaders such as Samsung Electronics CO LTD, Qualcomm Inc. and LG Corp., collectively holding more than 6,300 patents, have been progress in the progress of the IA and predictive analysis. Geographically, the United States takes the lead in patent deposits from Europe and the Asia-Pacific region also showing important contributions.
Technological sections and segments analysis
The technological progress of artificial intelligence is the main momentum behind the high rate of patent deposits. More than 6,000 patents focus on IA -led image analysis, which underlines the pivotal role of AI in improving diagnostic precision in health care. Integration with imaging methods is another focal point, with approximately 3,800 patents deposited in technologies that facilitate image analysis in real time. Data -based diagnoses and personalized medicine also remain key innovation areas.
In terms of market segmentation, software solutions maintain a predominant position in the patent landscape, with patents based on services. The application of AI leads in particular in neurology, followed by radiology and oncology, which also illustrates the wide potential of AI by meeting various medical diagnostic needs.
Patient centered care and adoption of end users
The environment of the end user deeply influences the activity of patents, hospitals showing the largest amount of deposits, indicating their central role in assimilation of AI for diagnoses. Diagnostic centers also significantly contribute to the landscape, focusing on specialized AI -focused services. This suggests that the field of medical diagnostics is gaining more and more AI in a range of health environments to provide improved care for patients.
Regional innovation and analysis of patent jurisdiction
Regional innovation is marked by a jurisdictional variation, the United States emphasizing AI progress to refine the diagnosis. In Europe, patent deposits focus on the synergy of AI and imaging technologies. Meanwhile, the Asia-Pacific region, in particular China and Japan, has a demand for evolutionary and profitable AI solutions, adaptable pioneer technologies for various diagnostic needs. Strategic implications on
Future of medical diagnoses
The patent landscape reflects not only the current technological progress of artificial intelligence for medical diagnoses, but also prepares the way for future innovations. The balance between software and services focused on services, innovation specific to the region and a commitment to patient care by the main participants in the industry describe the strategic contours of AI in health care.
It also illustrates the potential of AI to revolutionize medical diagnostics, powered the industry to unprecedented growth and efficiency. In conclusion, the projected growth of AI on the medical diagnostic market, supported by a vigorous patent activity and technological progress, announces a transformer era in health care, where precision diagnostics and improved results for patients are becoming more and more accessible.
Key attributes:
| Report attribute | Details |
| Number of pages | 200 |
| Forecast period | 2024 – 2032 |
| Estimated market value (USD) in 2024 | $ 1.7 billion |
| Planned market value (USD) by 2032 | $ 19.5 billion |
| Compound annual growth rate | 36.1% |
| Covered regions | Global |
Featured companies
- IBM
- NVIDIA Corp
- Samsung Electronics Co Ltd
- LG Corp.
- Koninklijke Philips NV
- Siemens Healthcare GmbH
- Qualcomm Inc.
- Strong Force Iot Portfolio 2016 LLC
- Cilag Gmbh int
- Ethicon LLC
- Gen Electric
- KPN Innovations LLC
- Ge Prec Healthcare LLC
- Tran bao
- Yue Henry
- Baughn Mariah R
- Pharmaceuticals Genissance
- Paige ai inc
- Tang y tom
- Medtronic Inc
- Rom Tech Inc
- Tempus Labs Inc
- UBIOME INC
- Univ Johns Hopkins
- Yao Monique G
- Incyte Genomics Inc
- Univ California
- FLEXTRONICS AP LLC
- Read dyung aina m
- Elliott Vicki S
- Gandhi Ameena R
- Hello inc
- Strong Force TX Portfolio 2018 LLC
- LAL PREETI G
- Hafalia April JA
- Verrint Americas Inc
- Chawla Narinder K
- Gecko Robotics Inc
- Ramkumar Jayalaxmi
- DEXCOM INC
- Intuitive surgery
- Intel Corp
- Automotive Tech Int
- Lu Yan
- Nguyen Dantiel B
- Ericsson Telefon Ab Lm
For more information on this report, visit https://www.researchandmarkets.com/r/4jbwdl
About Researchandmarkets.com
Researchandmarkets.com is the world’s main source of international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, main companies, new products and latest trends.